Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
- Status
- COMPLETED
- Phase
- N/A
A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)
- Status
- TERMINATED
- Phase
- PHASE2
Immune Modulation Therapy for Pompe Disease
- Status
- UNKNOWN
- Phase
- PHASE4
Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Belimumab Impacting Transplant Eligibility
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma
- Status
- COMPLETED
- Phase
- N/A
KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1
- Status
- COMPLETED
- Phase
- N/A
A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2